Reto Jost
Category Lead Large Volume Injectors

Is this your profile?

About

Reto Jost is Category Lead for Large Volume Injectors at Ypsomed Delivery Systems.

He has been with Ypsomed since 2014 in various roles in product management and business development, working with pharmaceutical companies to develop innovative self-injection systems and bring them to market. Since 2018, his main focus has been on new product innovation, with a particular focus on large-volume injections.

Reto holds an MSc in Mechanical Engineering from ETH Zurich (Switzerland) and a CAS in Business Administration from HES-SO (Fribourg, Switzerland). He has broad experience in medical devices, having worked in the industry since 2006.

Contributions

SUBCUTANEOUS DRUG DELIVERY: ADAPTING TO HIGH-VISCOSITY, LARGE-VOLUME DEMANDS

Thomas Fontanellaz, Reto Jost and Andreas Schneider discuss how Ypsomed is addressing the growing need for subcutaneous injections that accommodate higher volumes and viscosities, with innovative self-injection devices designed to enhance patient comfort and adherence.

More contributions

INTERVIEW: THE BENEFITS OF BEING AN EARLY ADOPTER OF SUSTAINABILITY PRINCIPLES

Reto Jost and Gabriel Kalbermatter talk exclusively with ONdrugDelivery's Guy Furness, discussing the progress Ypsomed has made in advancing its sustainability agenda, particularly the implementation of its ecodesign guideline, the benefits of being an early adopter of sustainability principles, how YpsoMate 5.5 mL has been designed from the ground up with sustainability in mind and where sustainability considerations currently fit into the wider pharma industry.

#138_2022_Oct_Ypsomed_Featured

THE NEW YPSOMATE™ 5.5 – TAKING HANDHELD SELF-INJECTION BEYOND VOLUMES OF 2 ML

Reto Jost introduces YpsoMate 5.5, the staked-needle-syringe-based, two-step autoinjector for injection volumes in the 2.0–5.5 mL range, and discusses the drivers of the demand for high-volume, high-rate subcutaneous drug delivery using handheld autoinjectors.

SIMPLIFYING LARGE-VOLUME PATCH INJECTION FOR PHARMA AND PATIENTS

Reto Jost provides an update on the YpsoDose platform and its importance as the driver for the business unit’s new patch injector franchise.

Top